Group 1 - Oil prices experienced a slight increase amid ongoing tensions in the Middle East [1] - Stock market recovery efforts were hindered as traders expressed skepticism about a quick resolution to the regional conflict [1]

Group 1 - Conagra Brands Inc is set to report its fiscal third-quarter earnings on April 1, following a mixed performance in previous reports, with the stock finishing in the red after five of the last eight earnings releases [1][2] - The options market anticipates a 4.9% price movement for Conagra Brands' stock, which is larger than the average 3.9% movement observed over the past two years [2] - The stock has been trading near its 16-year lows, attempting to bounce off the $15 level, but has experienced a 9% decline in 2026, with potential for recovery post-earnings [3] Group 2 - Options traders are currently leaning bearish, indicated by a put/call volume ratio of 1.78, ranking in the 92nd percentile of the last 12 months [5] - There is potential for upgrades, as 14 out of 16 brokerage firms have a "hold" or worse rating on the stock, while short interest has increased by 3.1% in the last two reporting periods, now accounting for 6.7% of the stock's float [6]

Core Viewpoint - Nike's current trading price of $52.71 is significantly below Wall Street's consensus target of $76, indicating a 44% upside potential, despite recent declines in revenue and net income due to various pressures [1][4][13]. Financial Performance - Nike's FY2025 revenue decreased by 9.84%, and net income fell by 43.53%, attributed to tariffs, increased discounting, and inventory clearance [1][6]. - Digital revenue dropped 14% year-over-year in Q2 FY2026, with Greater China revenue declining by 17% and Converse sales plummeting by 30% [1][7]. - North America revenue, however, grew by 9% year-over-year in Q2 FY2026, and wholesale channel revenue increased by 8% [9]. Analyst Sentiment - Despite the challenges, 59% of analysts maintain a bullish outlook on Nike, with a breakdown of five Strong Buys, 19 Buys, 13 Holds, one Sell, and one Strong Sell [8][13]. - Barclays upgraded Nike to Overweight in March, setting a price target of $73, citing signs of stabilization in North America [8]. Market Dynamics - The structural challenges include a shrinking direct-to-consumer channel and ongoing issues in the Greater China market, which is not stabilizing [2][15]. - Consumer sentiment remains weak, with the University of Michigan index at 55.5, indicating a cautious outlook for discretionary spending [9]. Recovery Potential - The recovery narrative hinges on continued growth in North America and stabilization of gross margins, with the CEO's recent stock purchase signaling confidence in a turnaround [9][14]. - The forward P/E ratio of 21x reflects expectations for earnings recovery that have yet to be realized in reported results [11].

Core Insights - Endava Plc (NYSE: DAVA) is positioned as a recovery setup following a cyclical reset year, with the stock previously down 45% in the preceding year [1] Company Analysis - The company has a focus on technology, infrastructure, and internet services, emphasizing strong fundamentals paired with real potential [1] - The analyst has a background in petroleum and gas engineering but transitioned to finance, indicating a diverse skill set that may benefit the analysis of Endava [1] Market Context - The article suggests that the market is reacting to the cyclical nature of the industry, which may present investment opportunities as the company recovers [1]

Group 1 - The search for Lululemon's next CEO is complicated by the lack of a clear succession plan, pressure from activist investor Elliot Investment Management, and founder Chip Wilson's attempts to replace board members [1] - The new CEO will need to focus on revitalizing the core U.S. business, which has seen a decline in comparable sales by 5% in the third quarter, while the international markets remain strong [2][3] - Lululemon's brand remains powerful, and there is potential for recovery if the company can successfully refresh its product mix, although this may take time due to the ongoing CEO search [5] Group 2 - The company has allowed its core products to stagnate amid increasing competition, and prior plans to decrease product development times and refresh the portfolio were announced before the CEO's resignation [4] - A stock recovery is anticipated in 2026, with the possibility of a clearer business comeback by 2027, as Lululemon stock is currently trading at around 16 times full-year earnings guidance, presenting a good opportunity for investors [6]

Core Viewpoint - Constellation Brands is facing significant challenges, including declining sales and rising tariffs, but there are signs that the stock may be oversold, potentially leading to a recovery in 2026 [1][9]. Company Performance - In the first half of fiscal 2026, Constellation Brands reported net sales of $5 billion, a decrease of over 10% compared to previous periods [4]. - The company earned $982 million during this period, an increase attributed to a goodwill impairment of nearly $2.3 billion in the first half of fiscal 2024 [4]. - The stock has lost almost 35% of its value over the last year [4]. Market Position - The current market capitalization of Constellation Brands is $26 billion, with a current stock price of $147.42 [5][6]. - The stock has a 52-week range of $126.45 to $240.32, indicating significant volatility [6]. Valuation and Dividends - The goodwill impairment has raised the price-to-earnings (P/E) ratio to 21, but the forward P/E of 13 is considered low [7]. - Constellation Brands has consistently paid and increased its dividend since 2015, with a current annual payout of $4.08 per share, resulting in a dividend yield of 2.8% [7]. Cash Flow and Share Buybacks - The company is projected to generate between $1.3 billion and $1.4 billion in free cash flow in fiscal 2026, sufficient to cover its annual dividend cost of approximately $725 million [8]. - The outstanding share count has decreased by over 3% in the last year, which may enhance the potential for share price recovery [8]. Future Outlook - Despite concerns over declining alcohol consumption and rising tariffs, the stock's 40% decline suggests that investors may have overreacted [9]. - Buying Constellation stock now allows investors to enter at a low valuation while benefiting from a high and rising dividend return, which could increase demand for shares [10].

Core Viewpoint - Oracle shares experienced a modest recovery of approximately 1% after a challenging period that diminished the excitement surrounding the company's record-setting cloud backlog [1] Group 1 - The stock has faced significant declines recently, leading to a loss of investor enthusiasm [1]

Group 1 - DAVE stock has decreased by 24.2% in less than a month, from $256.05 on October 27, 2025, to $194.10 currently [2] - The fintech firm offers a mobile app for personal finance management, including budgeting tools, banking, and lending solutions [2] - There is a favorable chance of stock recovery based on historical patterns following dips and an Attractive perspective on the stock [3] Group 2 - Buying during dips is an effective strategy for quality stocks, with DAVE stock meeting fundamental quality criteria [4] - The median return for the 12-month period following significant dips (defined as a decline of 30% or more within 30 days) is 11%, with a median peak return of 146% [4][9] - DAVE has experienced 7 instances since January 1, 2010, where the dip threshold of -30% within 30 days was met [6] Group 3 - To assess the risk of a dip indicating a worsening business scenario, it is essential to evaluate revenue growth, profitability, cash flow, and balance sheet stability [6] - A multi-asset portfolio can provide safer, smarter growth by stabilizing returns and reducing single-market risk [7] - The asset allocation strategy of Trefis' wealth management partner has consistently outperformed its benchmark, covering the S&P 500, S&P mid-cap, and Russell 2000 [8]

Core Insights - Cleveland-Cliffs Inc (NYSE:CLF) has seen a 2.1% increase in stock price, trading at $10.96, following a bounce off the $10 level, which coincides with the 126-day moving average that has historically captured several pullbacks [1] - The stock is currently up 16.2% for 2025 but remains significantly below its two-year high of $16.70 reached on October 20 [1] Short Interest - Short interest in Cleveland-Cliffs has decreased by 14% over the last two reporting periods, representing 10.9% of the stock's total available float [3] - At the average trading pace, it would take short sellers more than two days to cover these positions [3] Options Market - Options for Cleveland-Cliffs are currently considered affordable, with a Schaeffer's Volatility Index (SVI) of 67%, placing it in the 20th percentile of annual readings [4] - The company tends to outperform options traders' volatility expectations, as indicated by a Schaeffer's Volatility Scorecard (SVS) of 74 out of 100 [4]

Core Viewpoint - Stocks have recovered much of the losses incurred during Friday's trade, indicating a potential stabilization in the market as earnings reports are set to take center stage [1] Group 1 - The recovery in stock prices suggests a positive sentiment among investors following a period of volatility [1] - Upcoming earnings reports are anticipated to significantly influence market trends and investor decisions [1]